z-logo
open-access-imgOpen Access
Tailoring cancer therapy ‐ Validating basic science with the ‘supertrial’
Author(s) -
Wilkinson Emma
Publication year - 2009
Publication title -
molecular oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.332
H-Index - 88
eISSN - 1878-0261
pISSN - 1574-7891
DOI - 10.1016/j.molonc.2009.08.001
Subject(s) - paradigm shift , engineering ethics , cancer therapy , face (sociological concept) , set (abstract data type) , order (exchange) , precision medicine , medicine , computer science , management science , data science , cancer , sociology , epistemology , engineering , business , pathology , social science , philosophy , finance , programming language
A paradigm shift in research culture is needed in order to set up the large ambitious trials needed to make personalised medicine a reality. Emma Wilkinson talks to the experts about the hurdles they face and what needs to change.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here